Direct and indirect 5-HT receptor agonists produce gender-specific effects on locomotor and vertical activities in C57 BL/6J mice

Pharmacology Biochemistry and Behavior

Volumn 94, Issue 1, 2009, Pages 194-203

  Brookshire, Bethany R ^a   Jones, Sara R ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

8 OH DPAT; C57Bl 6J; Citalopram; DOI; Dopamine; Fluoxetine; Locomotor activity; MK 212; RU 24969; Serotonin; Sex; SR57227

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 AMINO 1 (6 CHLORO 2 PYRIDYL)PIPERIDINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; 6 CHLORO 2 (1 PIPERAZINYL)PYRAZINE; CITALOPRAM; FLUOXETINE; SEROTONIN 1A AGONIST; SEROTONIN 1B AGONIST; SEROTONIN 2A AGONIST; SEROTONIN 2C AGONIST; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; GENDER; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; AREA UNDER CURVE; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HABITUATION, PSYCHOPHYSIOLOGIC; INJECTIONS, INTRAPERITONEAL; MALE; MATCHED-PAIR ANALYSIS; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; PROTEIN ISOFORMS; RANDOM ALLOCATION; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEX CHARACTERISTICS; TIME FACTORS;

MUS;

EID: 70349192679     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.08.008     Document Type: Article

References (53)

1. Alex K.D., and Pehek E.A. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113 (2007) 296-320
2. Arvidsson L.E., Hacksell U., Nilsson J.L., Hjorth S., Carlsson A., Lindberg P., et al. 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. J Med Chem 24 (1981) 921-923
3. Bagdy G. Serotonin, anxiety, and stress hormones. Focus on 5-HT receptor subtypes, species and gender differences. Ann N Y Acad Sci 851 (1998) 357-363
4. Berridge C.W. Neural substrates of psychostimulant-induced arousal. Neuropsychopharmacology 31 (2006) 2332-2340
5. Bert B., Fink H., Hortnagl H., Veh R.W., Davies B., Theuring F., et al. Mice over-expressing the 5-HT(1A) receptor in cortex and dentate gyrus display exaggerated locomotor and hypothermic response to 8-OH-DPAT. Behav Brain Res 167 (2006) 328-341
6. Blanchard D.C., Shepherd J.K., Rodgers R.J., and Blanchard R.J. Evidence for differential effects of 8-OH-DPAT on male and female rats in the anxiety/defense test battery. Psychopharmacology (Berl) 106 (1992) 531-539
7. Borycz J., Zapata A., Quiroz C., Volkow N.D., and Ferre S. 5-HT 1B receptor-mediated serotoninergic modulation of methylphenidate-induced locomotor activation in rats. Neuropsychopharmacology 33 (2008) 619-626
8. Brocco M., Dekeyne A., Veiga S., Girardon S., and Millan M.J. Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents. Pharmacol Biochem Behav 71 (2002) 667-680
9. Bubar M.J., McMahon L.R., De Deurwaerdere P., Spampinato U., and Cunningham K.A. Selective serotonin reuptake inhibitors enhance cocaine-induced locomotor activity and dopamine release in the nucleus accumbens. Neuropharmacology 44 (2003) 342-353
10. Budygin E.A., Kilpatrick M.R., Gainetdinov R.R., and Wightman R.M. Correlation between behavior and extracellular dopamine levels in rat striatum: comparison of microdialysis and fast-scan cyclic voltammetry. Neurosci Lett 281 (2000) 9-12
11. Camp D.M., and Robinson T.E. Susceptibility to sensitization. I. Sex differences in the enduring effects of chronic d-amphetamine treatment on locomotion, stereotyped behavior and brain monoamines. Behav Brain Res 30 (1988) 55-68
12. Campbell A.D., Kohl R.R., and McBride W.J. Serotonin-3 receptor and ethanol-stimulated somatodendritic dopamine release. Alcohol 13 (1996) 569-574
13. Chaouloff F., Courvoisier H., Moisan M.P., and Mormede P. GR 127935 reduces basal locomotor activity and prevents RU 24969-, but not d-amphetamine-induced hyperlocomotion, in the Wistar-Kyoto hyperactive (WKHA) rat. Psychopharmacology (Berl) 141 (1999) 326-331
14. Chojnacka-Wojcik E. Involvement of dopamine autoreceptors in the hypoactivity induced by 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice. Pol J Pharmacol Pharm 44 (1992) 135-146
15. Christie J.E., and Crow T.J. Possible role of dopamine-containing neurones in the behavioural effects of cocaine. Br J Pharmacol 42 (1971) 643P-645P
16. Costall B., Eniojukan J.F., and Naylor R.J. Spontaneous climbing behaviour of mice, its measurement and dopaminergic involvement. Eur J Pharmacol 85 (1982) 125-132
17. Crowley J.J., Blendy J.A., and Lucki I. Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test. Psychopharmacology (Berl) 183 (2005) 257-264
18. de Angelis L. Experimental anxiety and antidepressant drugs: the effects of moclobemide, a selective reversible MAO-A inhibitor, fluoxetine and imipramine in mice. Naunyn Schmiedebergs Arch Pharmacol 354 (1996) 379-383
19. Dulawa S.C., Holick K.A., Gundersen B., and Hen R. Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 29 (2004) 1321-1330
20. Filip M., Bubar M.J., and Cunningham K.A. Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses. J Pharmacol Exp Ther 310 (2004) 1246-1254
21. Geyer M.A. Serotonergic functions in arousal and motor activity. Behav Brain Res 73 (1996) 31-35
22. Griffin III W.C., and Middaugh L.D. The influence of sex on extracellular dopamine and locomotor activity in C57BL/6J mice before and after acute cocaine challenge. Synapse 59 (2006) 74-81
23. Guertin P.A., and Steuer I. Ionotropic 5-HT3 receptor agonist-induced motor responses in the hindlimbs of paraplegic mice. J Neurophysiol 94 (2005) 3397-3405
24. Gustafson E.L., Durkin M.M., Bard J.A., Zgombick J., and Branchek T.A. A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5-ht7 receptor in rat brain. Br J Pharmacol 117 (1996) 657-666
25. Herve D., Pickel M., Joh T.H., and Beaudet A. Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons. Brain Res 435 (1987) 71-83
26. Hildebrandt M.G., Steyerberg E.W., Stage K.B., Passchier J., and Kragh-Soerensen P. Are gender differences important for the clinical effects of antidepressants?. Am J Psychiatry 160 (2003) 1643-1650
27. Holladay J.W., Dewey M.J., and Yoo S.D. Quantification of fluoxetine and norfluoxetine serum levels by reversed-phase high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl 704 (1997) 259-263
28. Holladay J.W., Dewey M.J., and Yoo S.D. Pharmacokinetics and antidepressant activity of fluoxetine in transgenic mice with elevated serum alpha-1-acid glycoprotein levels. Drug Metab Dispos 26 (1998) 20-24
29. Ikemoto S. Ventral striatal anatomy of locomotor activity induced by cocaine, d-amphetamine, dopamine and D1/D2 agonists. Neuroscience 113 (2002) 939-955
30. Kelly P.H. Unilateral 6-hydroxydopamine lesions of nigrostriatal or mesolimbic dopamine-containing terminals and the drug-induced rotation of rats. Brain Res 100 (1975) 163-169
31. Liang J., Wang X., Lu Y., Liu R., Zhang Q., Sun H., et al. Effects of antidepressants on the exploration, spontaneous motor activity and isolation-induced aggressiveness in mice. Beijing Da Xue Xue Bao 35 (2003) 54-60
32. Maj J., Rogoz Z., Skuza G., and Wedzony K. The synergistic effect of fluoxetine on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist. J Neural Transm 103 (1996) 131-146
33. Martin J.R., Bos M., Jenck F., Moreau J., Mutel V., Sleight A.J., et al. 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential. J Pharmacol Exp Ther 286 (1998) 913-924
34. Mateo Y., Budygin E.A., John C.E., and Jones S.R. Role of serotonin in cocaine effects in mice with reduced dopamine transporter function. Proc Natl Acad Sci U S A 101 (2004) 372-377
35. Minabe Y., Ashby Jr. C.R., and Wang R.Y. The effect of acute and chronic LY 277359, a selective 5-HT3 receptor antagonist, on the number of spontaneously active midbrain dopamine neurons. Eur J Pharmacol 209 (1991) 151-156
36. Murphy N.P., Lam H.A., and Maidment N.T. A comparison of morphine-induced locomotor activity and mesolimbic dopamine release in C57BL6, 129Sv and DBA2 mice. J Neurochem 79 (2001) 626-635
37. Neisewander J.L., and Acosta J.I. Stimulation of 5-HT2C receptors attenuates cue and cocaine-primed reinstatement of cocaine-seeking behavior in rats. Behav Pharmacol 18 (2007) 791-800
38. Ni Y.G., and Miledi R. Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac). Proc Natl Acad Sci U S A 94 (1997) 2036-2040
39. O'Dell L.E., Manzardo A.M., Polis I., Stouffer D.G., and Parsons L.H. Biphasic alterations in serotonin-1B (5-HT1B) receptor function during abstinence from extended cocaine self-administration. J Neurochem 99 (2006) 1363-1376
40. O'Dell L.E., and Parsons L.H. Serotonin1B receptors in the ventral tegmental area modulate cocaine-induced increases in nucleus accumbens dopamine levels. J Pharmacol Exp Ther 311 (2004) 711-719
41. O'Neill M.F., Fernandez A.G., and Palacios J.M. GR 127935 blocks the locomotor and antidepressant-like effects of RU 24969 and the action of antidepressants in the mouse tail suspension test. Pharmacol Biochem Behav 53 (1996) 535-539
42. Onaivi E.S., Bishop-Robinson C., Darmani N.A., and Sanders-Bush E. Behavioral effects of (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, (DOI) in the elevated plus-maze test. Life Sci 57 (1995) 2455-2466
43. Pessia M., Jiang Z.G., North R.A., and Johnson S.W. Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro. Brain Res 654 (1994) 324-330
44. Przegalinski E., Siwanowicz J., Nowak E., Papla I., and Filip M. Role of 5-HT(1B) receptors in the sensitization to amphetamine in mice. Eur J Pharmacol 422 (2001) 91-99
45. Robinson T.E., Becker J.B., and Presty S.K. Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine: sex differences. Brain Res 253 (1982) 231-241
46. Rothman R.B., Blough B.E., and Baumann M.H. Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions. AAPS J 9 (2007) E1-E10
47. Schindler C.W., and Carmona G.N. Effects of dopamine agonists and antagonists on locomotor activity in male and female rats. Pharmacol Biochem Behav 72 (2002) 857-863
48. Smith C.B. Effects of d-amphetamine upon brain amine content and locomotor activity of mice. J Pharmacol Exp Ther 147 (1965) 96-102
49. Stanford J.A., Currier T.D., and Gerhardt G.A. Acute locomotor effects of fluoxetine, sertraline, and nomifensine in young versus aged Fischer 344 rats. Pharmacol Biochem Behav 71 (2002) 325-332
50. Walker E.A., Kohut S.J., Hass R.W., Brown Jr. E.K., Prabandham A., and Lefever T. Selective and nonselective serotonin antagonists block the aversive stimulus properties of MK212 and m-chlorophenylpiperazine (mCPP) in mice. Neuropharmacology 49 (2005) 1210-1219
51. Woods J.H., and Tessel R.E. Fenfluramine: amphetamine congener that fails to maintain drug-taking behavior in the rhesus monkey. Science 185 (1974) 1067-1069
52. Yoo J.H., Cho J.H., Yu H.S., Lee K.W., Lee B.H., Jeong S.M., et al. Involvement of 5-HT receptors in the development and expression of methamphetamine-induced behavioral sensitization: 5-HT receptor channel and binding study. J Neurochem 99 (2006) 976-988
53. Zhang L., Ma W., Barker J.L., and Rubinow D.R. Sex differences in expression of serotonin receptors (subtypes 1A and 2A) in rat brain: a possible role of testosterone. Neuroscience 94 (1999) 251-259